IC
ZURA icon

Ikarian Capital’s Zura Bio ZURA Stock Holding History

Ikarian Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.19M Buy
1,218,492
+25,000
+2% +$119K 0.77% 36
2026
Q1 		$7.1M Buy
1,193,492
+391,170
+49% +$2.36M 0.58% 49
2025
Q4 		$4.2M Sell
802,322
-1,330,000
-62% -$5.26M 0.33% 71
2025
Q3 		$9.23M Buy
+2,132,322
New +$3.83M 0.93% 30

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ikarian Capital's ZURA Position: Q2 2026 in Review

Ikarian Capital increased its Zura Bio (ZURA) stake by 2.1% in Q2 2026, buying an estimated $119K and bringing the position to 1,218,492 shares worth $7.19M. The position accounts for 0.77% of the portfolio, ranked #36.

Ikarian Capital first reported a position in ZURA in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.23M in Q3 2025. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Ikarian Capital held 1,218,492 shares of Zura Bio worth $7.19M as of Q2 2026.
  • Ikarian Capital bought 25,000 Zura Bio shares in Q2 2026, an estimated $119K.
  • Zura Bio made up 0.77% of Ikarian Capital's portfolio in Q2 2026, its #36 holding.
  • Ikarian Capital first reported a position in Zura Bio in Q3 2025 and has held it in 4 quarters since.
  • Ikarian Capital's Zura Bio position peaked at $9.23M in Q3 2025.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.